Estradiol Transdermal System Usp, 0.025mg Per Day (93d304a6 249a 4887 9a4a Dfedbd209cc1 01)
Estradiol Patch
Product Images NDC 70771-1402
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 70771-1402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Estradiol Transdermal System Usp, 0.0375mg Per Day (93d304a6 249a 4887 9a4a Dfedbd209cc1 02)
Estradiol Transdermal System Usp, 0.05mg Per Day (93d304a6 249a 4887 9a4a Dfedbd209cc1 03)
This text appears to be a description for a transdermal system used for hormone therapy. The system contains estradiol and is intended to be applied once a week for continuous delivery. Each system contains 3.777 mg of estradiol USP, providing 0.05 mg of estradiol per day. The system is made up of various inactive components such as acrylic adhesive, colloidal silicon dioxide, and polyethylene backing. The package warns to keep the system out of reach of children and to store it at temperatures between 20°C and 25°C. The text also includes information about the manufacturer, Zydus Lifesciences Ltd. Overall, this product seems to be designed for transdermal administration of estradiol for hormone replacement therapy.*
Estradiol Transdermal System Usp, 0.06mg Per Day (93d304a6 249a 4887 9a4a Dfedbd209cc1 04)
Estradiol Transdermal System Usp, 0.075mg Per Day (93d304a6 249a 4887 9a4a Dfedbd209cc1 05)
Estradiol Transdermal System Usp, 0.1mg Per Day (93d304a6 249a 4887 9a4a Dfedbd209cc1 06)
This is a description of an estradiol transdermal system, which is a medication used for hormone replacement therapy. The system is to be applied once weekly on the skin, and each system contains 7.553 mg of estradiol USP, providing 0.1 mg of estradiol per day. The system is intended to be worn for 7 days. The inactive components of the system include acrylic adhesive, colloidal silicon dioxide, ethyl oleate, glyceryl monolaurate, isopropyl myristate, povidone, and polyethylene backing. The medication should be stored at a temperature between 20°C and 25°C (68°F and 77°F) and should not be stored above 86°F (30°C). It is important to keep the medication out of the reach of children. The product is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India. The description also includes the National Drug Code (NDC) for the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
